One-Pot Enzymatic Synthesis and Biological Evaluation of Ganglioside GM3 Derivatives as Potential Cancer Immunotherapeutics
作者:Juntao Wang、Dan Lu、Ran Sun、Shuwen Lei、Shuhua Luo、Xin Dang、Yang Zhang、Chang Yuan、Yong Zhang、Jinhong Wu、Guangyu Yang、Lei Fu、Faqin Jiang
DOI:10.1021/acs.jmedchem.1c01301
日期:2022.2.10
worldwide. Recent research studies have revealed that GM3 derivatives have considerable promise as potential therapeutic agents for cancer. To discover novel GM3 derivatives as potential antitumor agents, a one-pot enzymatic synthesis was established, yielding 14 GM3 derivatives in high total yields (22–41%). Subsequently, the inhibitory activities of GM3 derivatives were assessed by wound-healing assays
癌症是全世界死亡的主要原因。最近的研究表明,GM3 衍生物作为潜在的癌症治疗剂具有广阔的前景。为了发现新型 GM3 衍生物作为潜在的抗肿瘤药物,建立了一锅酶法合成方法,以高总产率 (22-41%) 产生了 14 种 GM3 衍生物。随后,通过伤口愈合试验和Transwell试验以及荷瘤动物模型评估了GM3衍生物的抑制活性。在所有GM3衍生物中, N-12在细胞中表现出优异的迁移和侵袭抑制作用,并且在C57BL/6小鼠中具有显着的抗肿瘤活性。随后对癌症组织和血清样本的分析表明, N-12可诱导肿瘤抑制,这与免疫反应密切相关。总而言之, N-12可以进一步开发为治疗癌症的有效疗法。然后进行 RNA 测序 (RNA-seq) 分析,结果表明N-12的抗肿瘤机制涉及粘着斑和 ECM-受体相互作用信号通路。